To ask the Scottish Government what action it is taking to improve the diagnosis and treatment of thyroid disorders. (S5O-01546)
Official Report · Chamber
Thyroid Disorders
General Question Time
Speakers
Choose an MSP to read only their contributions- Elaine Smith Lab 2
- Shona Robison SNP 2
The record
4 contributionsThe Scottish Government’s role is to provide policies, frameworks and resources to national health service boards to allow them to deliver services, taking account of national guidance set out by the British Thyroid Association. A clinician’s prime duty is to do no harm and, in making a diagnosis, we expect clinicians not only to take account of all the evidence presented to them, which will include test results, but to consider each patient’s symptoms, circumstances and experiences.
We expect all clinicians to demonstrate a patient-centred approach through full engagement and shared decision making on mutually agreed outcomes. That approach is at the heart of all Scottish Government policies and, in particular, the chief medical officer’s report “Realising Realistic Medicine”.
I thank the cabinet secretary for that encouraging response. I was pleased that, in response to my recent members’ business debate, a commitment was made to help thyroid sufferers. There has also been good news in NHS England, as triiodothyronine—or T3—will not be removed from the prescribed medicines list after a successful patient-led campaign. However, we need a clear answer on T3 here in Scotland. Will the cabinet secretary confirm that general practitioners and health boards will continue to prescribe that life-saving medicine?
As T3 is licensed, it can continue to be prescribed on the NHS. There are no plans to remove T3 from NHS Scotland. Formularies are set and agreed by boards based on recommendations from local clinicians, clinical expert groups, the latest clinical evidence and any recommendations that come via the Scottish Medicines Consortium.
In my initial response, I should have paid tribute to Elaine Smith’s work in this area over a long period. It is recognised that a small proportion of patients do not tolerate thyroxine—or T4—which is the main prescribed drug for treatment in this area, so T3 is available where the clinician is satisfied that it is the safest and most clinically effective treatment option for the individual patient concerned. That is how things have been done and it is how matters should continue to be done.
Motions, questions and votes
Linked from this item of the Official ReportIn this meeting
Everything on 7 Dec 2017 →- A75 and A77 Questions · 4
- Non-domestic Rates Questions · 6
- Thyroid Disorders Questions · 4
- Scottish-Irish Relations (Post-Brexit) Questions · 4
- Salvesen v Riddell Case Questions · 6
- NHS Fife (Meetings) Questions · 6
- NHS Grampian (Funding) Questions · 7
- Named Person Scheme First Minister’s Questions · 10
- Local Government Funding First Minister’s Questions · 8
- Fife Rape and Sexual Assault Centre First Minister’s Questions · 2
- Integration Joint Boards (Major Service Changes) First Minister’s Questions · 2
- Paisley (United Kingdom City of Culture 2021 Bid) First Minister’s Questions · 2
- Waverley Line (Performance) First Minister’s Questions · 2
- Rail Fares First Minister’s Questions · 4
- Brexit First Minister’s Questions · 5
- Middle East First Minister’s Questions · 2
- Accident and Emergency Waiting Times First Minister’s Questions · 2
- Knife Crime First Minister’s Questions · 6
- Organ Donation First Minister’s Questions · 4
- General Teaching Council for Scotland First Minister’s Questions · 4
- Brain Tumour Awareness Members’ business · 16
- Air Quality (Low-emission Zones) Statement · 25
- Sea Fisheries and End-year Negotiations Debate · 59
- Decision Time Decision time · 10
The type of each item (debate, statement, questions, members’ business and so on) and the times shown are worked out by this site from headings, the chair’s opening words and the Official Report’s running timestamps. They are not the Parliament’s own classification. Text: the Scottish Parliament Official Report.